Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06782529
PHASE4

Knee Injections for Obese Patients With Knee Arthritis

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

Official title: Comparison of Varying Doses of Steroid for Intra-articular Knee Injections

Key Details

Gender

All

Age Range

55 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-01-24

Completion Date

2027-01-24

Last Updated

2026-03-10

Healthy Volunteers

No

Interventions

DRUG

Triamcinolone Acetonide Low Dose

Subjects will receive a reduced dose of 20mg of triamcinolone acetonide. Total injection volume of 5ml, consisting of: * 0.5ml triamcinolone acetonide (20mg) * 4.5ml lidocaine (45mg)

DRUG

Triamcinolone Acetonide Standard Dose

Subjects will receive the standard of care dose of 40mg triamcinolone acetonide Total injection volume of 5ml, consisting of: * 1ml triamcinolone acetonide (40mg) * 4ml lidocaine (40mg)

Locations (1)

Mayo Clinic in Florida

Jacksonville, Florida, United States